N/A
Completed N=508
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Over Active Bladder
Source: ClinicalTrials.gov NCT01260311 ↗
Enrolled (actual)
508
Serious AEs
0.0%
Results posted
Sep 2014
Primary outcomePrimary: Number of Participants With Adverse Events (AEs) by Seriousness, Severity and Relationship to Treatment — 21; 19; 0; 0 participants
Summary
This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Adverse Events (AEs) by Seriousness, Severity and Relationship to Treatment |
21; 19; 0; 0; 2; 2 | — |
Eligibility Criteria
Inclusion Criteria
- Over-active bladder
- Prescribed with Fesoterodine
Exclusion Criteria
- Hypersensitivity
- Urinary retention
Data sourced from ClinicalTrials.gov (NCT01260311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.